| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | B |
| 3. Samples | B |
| 4. Measurand | A |
| 5. Pre-Analytical | B |
| 6. Replicate Analysis | B |
| 7. Steady State | B |
| 8. Outlier Analysis | C |
| 9. Normality | A |
| 10. Variance Homogeneity | C |
| 11. ANOVA | B |
| 12. CI | C |
| 13. No of Results | C |
| 14. Concentrations | A |
| 15. Total Score | C8,10,12,13 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | S100B |
| Unit | ug / L |
| Overall Analytical Principle Method | Immunoassay; Not specified |
| Number of Subjects | 32 |
| Number of Subjects included in BV estimation | 32 |
| Ethinicity | Caucasian |
| Age Mean / Median | 59.1 |
| Age Min | |
| Age Max | |
| Age SD | 14.8 |
| Number of Males | |
| Number of Females | |
| State of Well Being |
Non-healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 1 |
| Study Duration Units | Year |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 4 |
| Interval Units | Year |
| Sampling Times | Start Time:
End Time: |
| Number of Samples | |
| Average Number of Samples Used for BV Estimation | 4.2 |
| Average Number of Replicates | |
| Estimates of CVi | 14.2 |
| Calculated Confidence Intervals of CVi | Lower: 12.29, Upper: 16.58 |
| Estimates of CVg | 66.3 |
| Calculated Confidence Intervals of CVg | Lower: 53.15, Upper: 87.91 |
| Analytical CV | 3.5 |
| Calculated Confidence Intervals of Analytical CV | Lower: 2.51, Upper: 5.78 |
| Measurand Mean | 0.0557 |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |